Table 1.
Variable | Vehicle | RASi | RASi/SGLT2i | RASi/SGLT2i/MRA |
---|---|---|---|---|
N | 20 | 20 | 20 | 20 |
Male (%) | 50 | 50 | 50 | 50 |
Weight (g) | 19.8±1.7 | 20.0±2.7 | 20.4±2.5 | 20.4±2.3 |
GFR (µl/min) | 181±32 | 188±33 | 187±38 | 185±36 |
UACR (mg/mg) | 51.6±57.7 | 55.7±64.6 | 51.5±44.3 | 49.4±44.4 |
RASi, renin-angiotensin-system inhibitor; MRA, mineralocorticoid receptor antagonist; UACR, urine albumin-creatinine ratio.